Eastman Chemical Company (EMN) - Net Assets
Based on the latest financial reports, Eastman Chemical Company (EMN) has net assets worth $6.04 Billion USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($14.86 Billion) and total liabilities ($8.82 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Eastman Chemical Company liquidity resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $6.04 Billion |
| % of Total Assets | 40.63% |
| Annual Growth Rate | 5.58% |
| 5-Year Change | 4.3% |
| 10-Year Change | 31.01% |
| Growth Volatility | 17.03 |
Eastman Chemical Company - Net Assets Trend (1993–2025)
This chart illustrates how Eastman Chemical Company's net assets have evolved over time, based on quarterly financial data. Also explore EMN total asset value for the complete picture of this company's asset base.
Annual Net Assets for Eastman Chemical Company (1993–2025)
The table below shows the annual net assets of Eastman Chemical Company from 1993 to 2025. For live valuation and market cap data, see EMN market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $6.04 Billion | +3.16% |
| 2024-12-31 | $5.85 Billion | +5.82% |
| 2023-12-31 | $5.53 Billion | +5.61% |
| 2022-12-31 | $5.24 Billion | -9.54% |
| 2021-12-31 | $5.79 Billion | -5.24% |
| 2020-12-31 | $6.11 Billion | +1.26% |
| 2019-12-31 | $6.03 Billion | +2.62% |
| 2018-12-31 | $5.88 Billion | +7.26% |
| 2017-12-31 | $5.48 Billion | +18.92% |
| 2016-12-31 | $4.61 Billion | +14.60% |
| 2015-12-31 | $4.02 Billion | +12.01% |
| 2014-12-31 | $3.59 Billion | -7.35% |
| 2013-12-31 | $3.88 Billion | +27.97% |
| 2012-12-31 | $3.03 Billion | +61.93% |
| 2011-12-31 | $1.87 Billion | +14.94% |
| 2010-12-31 | $1.63 Billion | +7.53% |
| 2009-12-31 | $1.51 Billion | -2.58% |
| 2008-12-31 | $1.55 Billion | -25.41% |
| 2007-12-31 | $2.08 Billion | +2.61% |
| 2006-12-31 | $2.03 Billion | +25.87% |
| 2005-12-31 | $1.61 Billion | +36.15% |
| 2004-12-31 | $1.18 Billion | +13.52% |
| 2003-12-31 | $1.04 Billion | -17.94% |
| 2002-12-31 | $1.27 Billion | -7.76% |
| 2001-12-31 | $1.38 Billion | -23.95% |
| 2000-12-31 | $1.81 Billion | +3.01% |
| 1999-12-31 | $1.76 Billion | -9.05% |
| 1998-12-31 | $1.93 Billion | +10.33% |
| 1997-12-31 | $1.75 Billion | +6.96% |
| 1996-12-31 | $1.64 Billion | +7.26% |
| 1995-12-31 | $1.53 Billion | +17.99% |
| 1994-12-31 | $1.29 Billion | +22.05% |
| 1993-12-31 | $1.06 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Eastman Chemical Company's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 857.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $10.11 Billion | 169.52% |
| Common Stock | $2.00 Million | 0.03% |
| Other Comprehensive Income | $-160.00 Million | -2.68% |
| Total Equity | $5.96 Billion | 100.00% |
Eastman Chemical Company Competitors by Market Cap
The table below lists competitors of Eastman Chemical Company ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Sibanye Stillwater Limited
F:47VS
|
$7.90 Billion |
|
SpareBank 1 Sør-Norge ASA
OL:SB1NO
|
$7.90 Billion |
|
PT Petrindo Jaya Kreasi Tbk
JK:CUAN
|
$7.90 Billion |
|
Engie Brasil Energia S.A.
SA:EGIE3
|
$7.91 Billion |
|
Frontline Ltd
OL:FRO
|
$7.89 Billion |
|
XP Inc
F:XP9
|
$7.89 Billion |
|
National Fuel Gas Company
NYSE:NFG
|
$7.89 Billion |
|
Axsome Therapeutics Inc
NASDAQ:AXSM
|
$7.88 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Eastman Chemical Company's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 5,779,000,000 to 5,961,000,000, a change of 182,000,000 (3.1%).
- Net income of 474,000,000 contributed positively to equity growth.
- Dividend payments of 381,000,000 reduced retained earnings.
- Share repurchases of 100,000,000 reduced equity.
- Other comprehensive income increased equity by 154,000,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $474.00 Million | +7.95% |
| Dividends Paid | $381.00 Million | -6.39% |
| Share Repurchases | $100.00 Million | -1.68% |
| Other Comprehensive Income | $154.00 Million | +2.58% |
| Other Changes | $35.00 Million | +0.59% |
| Total Change | $- | 3.15% |
Book Value vs Market Value Analysis
This analysis compares Eastman Chemical Company's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.50x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 12.08x to 1.50x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1993-12-31 | $6.42 | $77.53 | x |
| 1994-12-31 | $7.79 | $77.53 | x |
| 1995-12-31 | $9.27 | $77.53 | x |
| 1996-12-31 | $10.33 | $77.53 | x |
| 1997-12-31 | $11.12 | $77.53 | x |
| 1998-12-31 | $12.16 | $77.53 | x |
| 1999-12-31 | $11.18 | $77.53 | x |
| 2000-12-31 | $11.78 | $77.53 | x |
| 2001-12-31 | $8.98 | $77.53 | x |
| 2002-12-31 | $8.23 | $77.53 | x |
| 2003-12-31 | $6.76 | $77.53 | x |
| 2004-12-31 | $7.56 | $77.53 | x |
| 2005-12-31 | $9.85 | $77.53 | x |
| 2006-12-31 | $12.18 | $77.53 | x |
| 2007-12-31 | $12.42 | $77.53 | x |
| 2008-12-31 | $10.22 | $77.53 | x |
| 2009-12-31 | $10.29 | $77.53 | x |
| 2010-12-31 | $11.01 | $77.53 | x |
| 2011-12-31 | $13.07 | $77.53 | x |
| 2012-12-31 | $19.75 | $77.53 | x |
| 2013-12-31 | $24.26 | $77.53 | x |
| 2014-12-31 | $23.23 | $77.53 | x |
| 2015-12-31 | $26.31 | $77.53 | x |
| 2016-12-31 | $30.63 | $77.53 | x |
| 2017-12-31 | $37.60 | $77.53 | x |
| 2018-12-31 | $40.61 | $77.53 | x |
| 2019-12-31 | $43.02 | $77.53 | x |
| 2020-12-31 | $44.12 | $77.53 | x |
| 2021-12-31 | $41.60 | $77.53 | x |
| 2022-12-31 | $41.26 | $77.53 | x |
| 2023-12-31 | $45.71 | $77.53 | x |
| 2024-12-31 | $49.02 | $77.53 | x |
| 2025-12-31 | $51.57 | $77.53 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Eastman Chemical Company utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 7.95%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.42%
- • Asset Turnover: 0.59x
- • Equity Multiplier: 2.49x
- Recent ROE (7.95%) is below the historical average (15.26%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1993 | -19.70% | -5.35% | 0.90x | 4.09x | $-315.10 Million |
| 1994 | 25.95% | 7.76% | 0.99x | 3.38x | $206.50 Million |
| 1995 | 36.58% | 11.09% | 1.04x | 3.18x | $406.20 Million |
| 1996 | 23.18% | 7.95% | 0.91x | 3.21x | $216.10 Million |
| 1997 | 16.31% | 6.11% | 0.81x | 3.30x | $110.70 Million |
| 1998 | 12.87% | 5.56% | 0.76x | 3.04x | $55.60 Million |
| 1999 | 2.73% | 1.05% | 0.73x | 3.58x | $-127.90 Million |
| 2000 | 16.72% | 5.73% | 0.81x | 3.61x | $121.80 Million |
| 2001 | -12.99% | -3.32% | 0.89x | 4.42x | $-316.80 Million |
| 2002 | 4.80% | 1.15% | 0.85x | 4.94x | $-66.10 Million |
| 2003 | -25.89% | -4.66% | 0.93x | 5.97x | $-374.30 Million |
| 2004 | 14.36% | 2.58% | 1.12x | 4.96x | $51.60 Million |
| 2005 | 34.55% | 7.89% | 1.22x | 3.58x | $395.80 Million |
| 2006 | 20.16% | 5.49% | 1.21x | 3.04x | $206.10 Million |
| 2007 | 14.41% | 4.39% | 1.14x | 2.89x | $91.80 Million |
| 2008 | 22.28% | 5.14% | 1.27x | 3.40x | $190.70 Million |
| 2009 | 8.99% | 2.71% | 0.91x | 3.65x | $-15.30 Million |
| 2010 | 26.92% | 7.55% | 0.96x | 3.70x | $275.30 Million |
| 2011 | 37.22% | 9.70% | 1.16x | 3.31x | $509.00 Million |
| 2012 | 14.84% | 5.42% | 0.69x | 3.95x | $142.60 Million |
| 2013 | 30.69% | 12.45% | 0.79x | 3.12x | $785.40 Million |
| 2014 | 21.40% | 7.90% | 0.59x | 4.58x | $400.00 Million |
| 2015 | 21.52% | 8.87% | 0.61x | 3.96x | $453.90 Million |
| 2016 | 19.05% | 9.68% | 0.58x | 3.40x | $411.50 Million |
| 2017 | 26.83% | 15.49% | 0.59x | 2.91x | $924.60 Million |
| 2018 | 18.61% | 10.67% | 0.63x | 2.76x | $499.70 Million |
| 2019 | 12.74% | 8.21% | 0.58x | 2.69x | $163.20 Million |
| 2020 | 7.94% | 5.65% | 0.53x | 2.67x | $-124.30 Million |
| 2021 | 15.02% | 8.18% | 0.68x | 2.72x | $286.60 Million |
| 2022 | 15.39% | 7.53% | 0.72x | 2.85x | $277.70 Million |
| 2023 | 16.38% | 9.71% | 0.63x | 2.68x | $348.20 Million |
| 2024 | 15.66% | 9.65% | 0.62x | 2.63x | $327.10 Million |
| 2025 | 7.95% | 5.42% | 0.59x | 2.49x | $-122.10 Million |
Industry Comparison
This section compares Eastman Chemical Company's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $733,290,376
- Average return on equity (ROE) among peers: 5.82%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Eastman Chemical Company (EMN) | $6.04 Billion | -19.70% | 1.46x | $7.90 Billion |
| Albemarle Corp (ALB) | $1.03 Billion | 13.91% | 1.46x | $19.80 Billion |
| Alto Ingredients Inc (ALTO) | $383.70 Million | -9.11% | 0.88x | $212.84 Million |
| Aemetis Inc (AMTX) | $-35.29 Million | 0.00% | 0.00x | $154.69 Million |
| Air Products and Chemicals Inc (APD) | $3.09 Billion | 14.58% | 1.67x | $62.29 Billion |
| Ashland Global Holdings Inc (ASH) | $971.00 Million | 21.48% | 2.92x | $2.37 Billion |
| Avient Corp (AVNT) | $649.70 Million | 1.75% | 1.44x | $3.16 Billion |
| Axalta Coating Systems Ltd (AXTA) | $1.21 Billion | -18.56% | 4.56x | $5.92 Billion |
| Balchem Corporation (BCPC) | $1.80 Million | 22.22% | 1.00x | $5.17 Billion |
| BioNexus Gene Lab Corp Common stock (BGLC) | $6.67 Million | -5.34% | 0.31x | $4.91 Million |
| Bon Natural Life Ltd (BON) | $26.53 Million | 17.30% | 0.37x | $7.91 Million |
About Eastman Chemical Company
Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat tra… Read more